I

Immunome

Antibody-based therapeutic discovery and development

Senior Manager - Statistical Programming

Quantitative Biology & BiostatisticsPosted on Nov 14
Full-timeRemote in USA$175.5k - $201kRemote

About the Job

Requirements

  • A master's degree or higher in Statistics, Computer Science, or another closely related field to programming is required.
  • At least 6 years of relevant pharmaceutical or biotechnology industry experience is required.
  • Solid knowledge of statistical programming principles, clinical trials processes, and regulatory requirements is required.
  • Strong problem-solving and risk-mitigation skills are required.
  • Verbal, written, and interpersonal skills are required to communicate and collaborate effectively with cross-functional teams in person, by telephone, and by email.
  • Working knowledge of ICH, FDA, and GCP regulations and guidelines is required.
  • Technical skills in SAS, EDC systems, Microsoft Word, Excel, PowerPoint, API-based data extracts, and ETL principles are required.
  • Knowledge of CDISC, SDTM, CDASH, and ADaM industry standards is required.

Responsibilities

  • Lead statistical programming activities for one or two assigned clinical studies, ensuring high-quality deliverables across the full study lifecycle.
  • Develop or review programming specifications based on the Statistical Analysis Plan and oversee the creation, validation, and delivery of CDISC-compliant SDTM and ADaM datasets, tables, listings, and figures, Define.xml, and reviewer guides.
  • Provide hands-on SAS programming support for key analyses, data exploration, ad hoc requests, and internal or regulatory deliverables as needed.
  • Manage study programming timelines, coordinate dependencies, identify risks, and align work with cross-functional study plans and key milestones.
  • Collaborate with Biostatistics, Data Management, Clinical Operations, and Safety teams to review requirements, refine specifications, and resolve data or programming issues.
  • Review Data Management Plans, case report forms, data transfer specifications, external and vendor data specifications, and validation-related documentation to ensure data quality and downstream programming readiness.
  • Oversee CRO statistical programming activities, review outputs for accuracy and compliance, and ensure timely, high-quality delivery of datasets and analysis results.
  • Validate CRO-generated SDTM and ADaM datasets, tables, listings, and figures, and submission components using Pinnacle 21 to assess CDISC compliance and support resolution of identified issues.
  • Develop and maintain SAS macros, utilities, programming standards, and reusable tools to improve efficiency, consistency, and scalability across studies.
  • Ensure adherence to CDISC standards, regulatory expectations, departmental SOPs, and best practices for statistical programming and data traceability.
  • Mentor and provide technical oversight to junior programmers or contractors supporting assigned studies.
  • Contribute to and, where appropriate, lead departmental initiatives, process improvements, and cross-functional projects beyond assigned study responsibilities.

Desired Qualifications

  • Prior NDA submission and regulatory agency interaction experience is highly desirable.
  • Prior oncology or hematology experience is highly desirable.

About the Company

Immunome

Antibody-based therapeutic discovery and development

Immunome identifies antibodies and their targets by studying the immune systems of patients who recover from diseases, to develop first-in-class therapeutics. Its platform analyzes immune responses to discover novel antibodies and their targets, which are then advanced through research and development in partnership with healthcare and medical research clients. The company’s products work by using antibodies discovered from patients’ immune systems to target diseases, potentially enabling new treatments across oncology and other areas. Immunome differentiates itself through a proprietary discovery platform that extracts clinically relevant antibodies from real patient immune responses, enabling collaborations and licensing deals rather than solely pursuing standalone drug sales. The goal is to bring new antibody therapies to patients by forming partnerships, licensing innovations, and eventually delivering approved therapies.

Company size
201-500
Company stage
IPO
Headquarters
Bothell, WA
Founded
2008

Recently Posted Jobs

Explore more opportunities at Immunome

See more jobs